Ind-Swift Laboratories Limited reported earnings results for the fourth quarter ended March 31, 2024. For the fourth quarter, the company reported sales was INR 3,933.35 million compared to INR 3,042.46 million a year ago. Revenue was INR 4,185.85 million compared to INR 314,452.6 million a year ago.

Net income was INR 2,388.22 million compared to net loss of INR 251.24 million a year ago. Basic earnings per share from continuing operations was INR 40.42 compared to basic loss per share from continuing operations of INR 4.25 a year ago. Diluted earnings per share from continuing operations was INR 40.42 compared to diluted loss per share from continuing operations of INR 4.25 a year ago.